IL125903A0 - Indole derivatives useful as endothelin receptor antagonists - Google Patents

Indole derivatives useful as endothelin receptor antagonists

Info

Publication number: IL125903A0
Authority: IL; Israel
Prior art keywords: receptor antagonists; indole derivatives; endothelin receptor; derivatives useful; useful
Prior art date: 1996-05-09

Application number

IL12590397A

Other languages

English (en)

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-09

Filing date

1997-04-11

Publication date

1999-04-11

1997-04-11 Application filed by Pfizer filed Critical Pfizer

1999-04-11 Publication of IL125903A0 publication Critical patent/IL125903A0/xx

Links

229940118365 Endothelin receptor antagonist Drugs 0.000 title 1
229940054051 antipsychotic indole derivative Drugs 0.000 title 1
239000002308 endothelin receptor antagonist Substances 0.000 title 1
150000002475 indoles Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

IL12590397A 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists IL125903A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9609641.7A GB9609641D0 (en)	1996-05-09	1996-05-09	Compounds useful in therapy
PCT/EP1997/001882 WO1997043260A1 (en)	1996-05-09	1997-04-11	Indole derivatives useful as endothelin receptor antagonists

Publications (1)

Publication Number	Publication Date
IL125903A0 true IL125903A0 (en)	1999-04-11

Family

ID=10793387

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12590397A IL125903A0 (en)	1996-05-09	1997-04-11	Indole derivatives useful as endothelin receptor antagonists

Country Status (42)

Country	Link
US (4)	US6017945A (de)
EP (1)	EP0901470B1 (de)
JP (1)	JP3245179B2 (de)
KR (1)	KR100331217B1 (de)
CN (1)	CN1124262C (de)
AP (1)	AP830A (de)
AR (1)	AR007030A1 (de)
AT (1)	ATE263151T1 (de)
AU (1)	AU717849B2 (de)
BG (1)	BG102873A (de)
BR (1)	BR9709072A (de)
CA (1)	CA2253876A1 (de)
CO (1)	CO4650036A1 (de)
CZ (1)	CZ292928B6 (de)
DE (1)	DE69728392T2 (de)
DK (1)	DK0901470T3 (de)
DZ (1)	DZ2227A1 (de)
EA (1)	EA001471B1 (de)
ES (1)	ES2218675T3 (de)
GB (1)	GB9609641D0 (de)
HN (1)	HN1997000058A (de)
HR (1)	HRP970249B1 (de)
HU (1)	HUP9901245A3 (de)
ID (1)	ID16878A (de)
IL (1)	IL125903A0 (de)
IS (1)	IS1856B (de)
MA (1)	MA26428A1 (de)
NO (1)	NO312547B1 (de)
NZ (1)	NZ332640A (de)
OA (1)	OA10896A (de)
PE (1)	PE65098A1 (de)
PL (1)	PL329725A1 (de)
PT (1)	PT901470E (de)
SI (1)	SI0901470T1 (de)
SK (1)	SK150398A3 (de)
TN (1)	TNSN97078A1 (de)
TR (1)	TR199802269T2 (de)
TW (1)	TW491838B (de)
UA (1)	UA50767C2 (de)
UY (1)	UY24546A1 (de)
WO (1)	WO1997043260A1 (de)
ZA (1)	ZA973963B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9722287D0 (en)	1997-10-22	1997-12-17	Pfizer Ltd	Compounds useful in therapy
BRPI0017548B8 (pt)	1999-02-10	2023-05-02	Astrazeneca Ab	Composto
US20050203166A1 (en) *	2000-06-30	2005-09-15	Cancer Research Technology Limited	Indole-3-acetic acid derivatives
GB0016162D0 (en) *	2000-06-30	2000-08-23	Cancer Res Campaign Tech	Indole-3-acetic acid derivatives
DE60221391T2 (de)	2001-06-20	2008-04-17	Wyeth	Substituierte indolsäurederivate als inhibitoren von plasminogen-aktivator-inhibitor-1 (pai-1)
TWI224101B (en)	2001-06-20	2004-11-21	Wyeth Corp	Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
AR037097A1 (es)	2001-10-05	2004-10-20	Novartis Ag	Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
BR0316574A (pt)	2002-12-10	2005-10-04	Wyeth Corp	Derivados de ácido acético 3-carbonil-1h-indol-1-il substituìdo como inibidores do inibidor-1 do ativador do plasminogênio (pai-1)
DK1569899T3 (da)	2002-12-10	2006-10-23	Wyeth Corp	Substituerede 3-alkyl- og 3-arylalkyl-1H-indol-1-yl-eddikesyrederivater som inhibitorer af plasminogenaktivator-inhibitor-1 (PAI-1)
UA80453C2 (en)	2002-12-10	2007-09-25		Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
CA2509191A1 (en)	2002-12-10	2004-06-24	Wyeth	Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
US7056943B2 (en)	2002-12-10	2006-06-06	Wyeth	Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
CN1742007A (zh) *	2003-01-22	2006-03-01	伊莱利利公司	甾族激素核受体的吲哚衍生物调控剂
US7534894B2 (en)	2003-09-25	2009-05-19	Wyeth	Biphenyloxy-acids
US7342039B2 (en)	2003-09-25	2008-03-11	Wyeth	Substituted indole oximes
US7351726B2 (en)	2003-09-25	2008-04-01	Wyeth	Substituted oxadiazolidinediones
US7582773B2 (en)	2003-09-25	2009-09-01	Wyeth	Substituted phenyl indoles
US7163954B2 (en)	2003-09-25	2007-01-16	Wyeth	Substituted naphthyl benzothiophene acids
US7265148B2 (en)	2003-09-25	2007-09-04	Wyeth	Substituted pyrrole-indoles
US7446201B2 (en)	2003-09-25	2008-11-04	Wyeth	Substituted heteroaryl benzofuran acids
US7420083B2 (en)	2003-09-25	2008-09-02	Wyeth	Substituted aryloximes
US7141592B2 (en)	2003-09-25	2006-11-28	Wyeth	Substituted oxadiazolidinediones
US7268159B2 (en)	2003-09-25	2007-09-11	Wyeth	Substituted indoles
US7411083B2 (en)	2003-09-25	2008-08-12	Wyeth	Substituted acetic acid derivatives
US7332521B2 (en)	2003-09-25	2008-02-19	Wyeth	Substituted indoles
US7442805B2 (en)	2003-09-25	2008-10-28	Wyeth	Substituted sulfonamide-indoles
JP2005109006A (ja) *	2003-09-29	2005-04-21	Tdk Corp	高電圧貫通型コンデンサ及びマグネトロン
HN2004000536A (es)	2003-12-16	2009-02-18	Wyeth Corp	Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
CA2577846A1 (en)	2004-08-23	2006-03-02	Wyeth	Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
US7754747B2 (en)	2004-08-23	2010-07-13	Wyeth Llc	Oxazolo-naphthyl acids
JP2008510814A (ja)	2004-08-23	2008-04-10	ワイス	Ｐａｉ−１阻害剤としてのピロロ−ナフチル酸
EP1919866A2 (de)	2005-08-17	2008-05-14	Wyeth a Corporation of the State of Delaware	Substituierte indole und deren verwendung
US20100022568A1 (en) *	2006-04-13	2010-01-28	Actelion Pharmaceeuticals Ltd.	Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
DE102008030207A1 (de)	2008-06-25	2009-12-31	Bayer Schering Pharma Aktiengesellschaft	Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
DE102008030206A1 (de)	2008-06-25	2009-12-31	Bayer Schering Pharma Aktiengesellschaft	3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
WO2018064465A1 (en)	2016-09-29	2018-04-05	The Regents Of The University Of California	Compounds for increasing neural plasticity
CN106674065A (zh) *	2016-12-07	2017-05-17	贵州大学	一种5‑卤代‑2‑烷氧基‑4‑甲苯磺酰氯制备方法
GB201817038D0 (en) *	2018-10-19	2018-12-05	Inflazome Ltd	Novel processes
JP7770673B2 (ja)	2019-02-27	2025-11-17	ザリージェンツオブザユニバーシティオブカリフォルニア	脳障害を治療するためのアゼピノ－インドール及び他の複素環化合物
AU2022416279A1 (en)	2021-12-15	2024-07-25	Delix Therapeutics, Inc.	Phenoxy and benzyloxy substituted psychoplastogens and uses thereof
CN117263832B (zh) *	2023-08-18	2026-02-03	辽宁龙田化工科技有限公司	一种2-氯-4-甲磺酰基苯甲酸合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL297888A (de) *	1962-09-14
DE1950346B2 (de) *	1968-10-08	1973-06-28	Sumitomo Chemical Co	2-indolylessigsaeureverbindungen und diese verbindungen enthaltende arzneipraeparate
US4397079A (en) *	1981-03-30	1983-08-09	International Business Machines Corp.	Process for improving the yield of integrated devices including Schottky barrier diodes
US5245046A (en) *	1988-11-14	1993-09-14	The Upjohn Company	α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
WO1992004321A1 (en) *	1990-09-10	1992-03-19	Rhone-Poulenc Rorer International (Holdings) Inc.	Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
ZA939516B (en) *	1992-12-22	1994-06-06	Smithkline Beecham Corp	Endothelin receptor antagonists
EP0617001B1 (de) *	1993-03-19	2000-01-26	Merck & Co. Inc.	Phenoxyphenylessigsäurederivate
GB9317096D0 (en) *	1993-08-17	1993-09-29	Pfizer Ltd	Indoles

1996
- 1996-05-09 GB GBGB9609641.7A patent/GB9609641D0/en active Pending
1997
- 1997-04-01 TW TW086104171A patent/TW491838B/zh not_active IP Right Cessation
- 1997-04-11 ES ES97920690T patent/ES2218675T3/es not_active Expired - Lifetime
- 1997-04-11 JP JP54042397A patent/JP3245179B2/ja not_active Expired - Fee Related
- 1997-04-11 CN CN97194016A patent/CN1124262C/zh not_active Expired - Fee Related
- 1997-04-11 UA UA98115906A patent/UA50767C2/uk unknown
- 1997-04-11 BR BR9709072A patent/BR9709072A/pt active Search and Examination
- 1997-04-11 SI SI9730646T patent/SI0901470T1/xx unknown
- 1997-04-11 DE DE1997628392 patent/DE69728392T2/de not_active Expired - Fee Related
- 1997-04-11 SK SK1503-98A patent/SK150398A3/sk unknown
- 1997-04-11 PT PT97920690T patent/PT901470E/pt unknown
- 1997-04-11 DK DK97920690T patent/DK0901470T3/da active
- 1997-04-11 NZ NZ332640A patent/NZ332640A/en unknown
- 1997-04-11 AU AU26978/97A patent/AU717849B2/en not_active Ceased
- 1997-04-11 HU HU9901245A patent/HUP9901245A3/hu unknown
- 1997-04-11 AT AT97920690T patent/ATE263151T1/de not_active IP Right Cessation
- 1997-04-11 US US09/147,096 patent/US6017945A/en not_active Expired - Fee Related
- 1997-04-11 PL PL97329725A patent/PL329725A1/xx unknown
- 1997-04-11 KR KR1019980709023A patent/KR100331217B1/ko not_active Expired - Fee Related
- 1997-04-11 EA EA199800908A patent/EA001471B1/ru not_active IP Right Cessation
- 1997-04-11 WO PCT/EP1997/001882 patent/WO1997043260A1/en not_active Ceased
- 1997-04-11 TR TR1998/02269T patent/TR199802269T2/xx unknown
- 1997-04-11 CZ CZ19983582A patent/CZ292928B6/cs not_active IP Right Cessation
- 1997-04-11 EP EP97920690A patent/EP0901470B1/de not_active Expired - Lifetime
- 1997-04-11 IL IL12590397A patent/IL125903A0/xx unknown
- 1997-04-11 CA CA002253876A patent/CA2253876A1/en not_active Abandoned
- 1997-04-29 HN HN1997000058A patent/HN1997000058A/es unknown
- 1997-05-02 PE PE1997000345A patent/PE65098A1/es not_active Application Discontinuation
- 1997-05-07 UY UY24546A patent/UY24546A1/es not_active IP Right Cessation
- 1997-05-07 MA MA24599A patent/MA26428A1/fr unknown
- 1997-05-07 DZ DZ970074A patent/DZ2227A1/fr active
- 1997-05-07 CO CO97024471A patent/CO4650036A1/es unknown
- 1997-05-07 AR ARP970101888A patent/AR007030A1/es not_active Application Discontinuation
- 1997-05-07 TN TNTNSN97078A patent/TNSN97078A1/fr unknown
- 1997-05-07 ID IDP971517A patent/ID16878A/id unknown
- 1997-05-08 AP APAP/P/1997/000982A patent/AP830A/en active
- 1997-05-08 ZA ZA973963A patent/ZA973963B/xx unknown
- 1997-05-09 HR HR970249A patent/HRP970249B1/xx not_active IP Right Cessation
1998
- 1998-08-28 IS IS4838A patent/IS1856B/is unknown
- 1998-10-09 OA OA9800192A patent/OA10896A/en unknown
- 1998-10-27 BG BG102873A patent/BG102873A/xx unknown
- 1998-11-09 NO NO19985225A patent/NO312547B1/no not_active IP Right Cessation
1999
- 1999-10-07 US US09/414,361 patent/US6136843A/en not_active Expired - Fee Related
2000
- 2000-04-24 US US09/556,651 patent/US6306852B1/en not_active Expired - Fee Related
2001
- 2001-01-09 US US09/756,835 patent/US6384070B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1124262C (zh)	2003-10-15
HN1997000058A (es)	1997-06-26
UA50767C2 (uk)	2002-11-15
PE65098A1 (es)	1998-10-29
ES2218675T3 (es)	2004-11-16
HUP9901245A2 (hu)	1999-08-30
NO312547B1 (no)	2002-05-27
HK1019149A1 (en)	2000-01-14
EA199800908A1 (ru)	1999-06-24
SI0901470T1 (en)	2004-08-31
CN1216531A (zh)	1999-05-12
EP0901470A1 (de)	1999-03-17
OA10896A (en)	2001-10-11
AU717849B2 (en)	2000-04-06
BR9709072A (pt)	1999-08-03
GB9609641D0 (en)	1996-07-10
WO1997043260A1 (en)	1997-11-20
HUP9901245A3 (en)	2002-01-28
CZ358298A3 (cs)	1999-08-11
IS4838A (is)	1998-08-28
JP3245179B2 (ja)	2002-01-07
TW491838B (en)	2002-06-21
HRP970249B1 (en)	2003-06-30
NO985225L (no)	1998-11-09
US20010014677A1 (en)	2001-08-16
TNSN97078A1 (fr)	2005-03-15
PL329725A1 (en)	1999-04-12
NZ332640A (en)	2001-03-30
JPH11508285A (ja)	1999-07-21
ATE263151T1 (de)	2004-04-15
IS1856B (is)	2003-02-21
KR100331217B1 (ko)	2002-05-09
AP830A (en)	2000-05-03
CA2253876A1 (en)	1997-11-20
AU2697897A (en)	1997-12-05
PT901470E (pt)	2004-07-30
TR199802269T2 (xx)	2001-12-21
CO4650036A1 (es)	1998-09-03
SK150398A3 (en)	1999-03-12
NO985225D0 (no)	1998-11-09
ZA973963B (en)	1998-11-09
DK0901470T3 (da)	2004-07-12
AP9700982A0 (en)	1997-07-31
DE69728392D1 (de)	2004-05-06
DE69728392T2 (de)	2005-01-13
MA26428A1 (fr)	2004-12-20
EP0901470B1 (de)	2004-03-31
CZ292928B6 (cs)	2004-01-14
DZ2227A1 (fr)	2002-12-25
UY24546A1 (es)	2000-09-29
HRP970249A2 (en)	1998-06-30
ID16878A (id)	1997-11-20
EA001471B1 (ru)	2001-04-23
US6136843A (en)	2000-10-24
BG102873A (en)	1999-11-30
US6306852B1 (en)	2001-10-23
US6384070B2 (en)	2002-05-07
AR007030A1 (es)	1999-10-13
KR20000010879A (ko)	2000-02-25
US6017945A (en)	2000-01-25

Publication	Publication Date	Title
SI0901470T1 (en)	2004-08-31	Indole derivatives useful as endothelin receptor antagonists
AU4746297A (en)	1998-04-24	Vitronectin receptor antagonists
HU9601529D0 (en)	1996-07-29	Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
GB9718913D0 (en)	1997-11-12	Substituted oxindole derivatives
EP0912175A4 (de)	1999-09-08	Antagonisten des fibrinogenrezeptors
AP9701036A0 (en)	1997-07-31	Indole derivatives as 5-HT receptor antagonist
IL123581A0 (en)	1998-10-30	Pyrimidine derivatives as 5HT2c- receptor antagonists
EP0885205A4 (de)	2002-11-27	Fibrinogen-rezeptor-antagonisten
EP0885213A4 (de)	1999-04-28	Fibrinogenrezeptor antagonisten
PL356990A1 (en)	2004-07-12	Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
HUP9903480A3 (en)	2002-12-28	Indoline derivatives useful as 5-ht-2c receptor antagonists
AU1296899A (en)	1999-05-31	Phenyl-alkyl-imidazoles as h3 receptor antagonists
HUP9903439A3 (en)	2002-12-28	Indoline derivatives useful as 5-ht-2c receptor antagonists
AU8871898A (en)	1999-03-22	Phenylindole derivatives as 5-ht2a receptor antagonists
AU3611099A (en)	1999-12-20	Oxindole derivatives used as neurokinin receptor antagonists
AU4980999A (en)	2000-02-01	A3 adenosine receptor antagonists
AU2943899A (en)	1999-10-11	Indole derivatives as 5-ht2a receptor antagonists
AU1150999A (en)	1999-05-10	Indole derivative useful as endothelin receptor antagonist
AU6826498A (en)	1998-10-12	Endotholin receptor antagonists
SI0912556T1 (en)	2001-02-28	Indoline derivatives useful as 5-ht-2c receptor antagonists
HK1019747A (en)	2000-02-25	Indoline derivatives useful as 5-ht-2c receptor antagonists
HK1020955A (en)	2000-05-26	Endothelin receptor antagonists
HK1023780A (en)	2000-09-22	G protein-coupled receptor antagonists
GB9811283D0 (en)	1998-07-22	Vironectin receptor antagonists
IL108842A0 (en)	1994-06-24	Benzylimidazopyridine derivatives as angiotensin II receptor antagonists